Browsing: Standard
Vutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), according…
While muscles need protein for optimal recovery, neglecting to support our connective tissues with the right type and amount of…
The combination of the antibody amivantamab and lazertinib, a drug that targets EGFR, shows better clinical benefits compared with standard…